AGIO (STOCKS)
Agios Pharmaceuticals, Inc.
$26.725000
-0.405000 (-1.49%)
Prev close: $27.130000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Brian M. Goff
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,593.68M
- Employees
- 488
- P/E (TTM)
- -3.90
- P/B (TTM)
- 1.23
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
7
Buy
4
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-1.78 | $-1.94 | +0.1567 | +8.09% |
|
Jun 2025 (Q2)
|
$-1.93 | $-1.84 | -0.0863 | -4.68% |
|
Mar 2025 (Q1)
|
$-1.55 | $-1.82 | +0.2694 | +14.81% |
|
Dec 2024 (Q4)
|
$-1.44 | $-1.72 | +0.2838 | +16.46% |
Financial Statements
| Revenues | $44.79M |
| Benefits Costs and Expenses | $454.93M |
| Cost Of Revenue | $5.73M |
| Costs And Expenses | $520.38M |
| Gross Profit | $39.07M |
| Operating Expenses | $514.66M |
| Selling, General, and Administrative Expenses | $180.37M |
| Research and Development | $334.29M |
| Operating Income/Loss | -$475.59M |
| Income/Loss From Continuing Operations After Tax | -$401.27M |
| Income/Loss From Continuing Operations Before Tax | -$410.14M |
| Income Tax Expense/Benefit | -$8.88M |
| Net Income/Loss | -$401.27M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$401.27M |
| Net Income/Loss Available To Common Stockholders, Basic | -$401.27M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$6.99 |
| Diluted Earnings Per Share | -$7.01 |
| Basic Average Shares | 115,934,567 |
| Diluted Average Shares | 116,144,343 |
| Assets | $1.39B |
| Current Assets | $1.03B |
| Cash | $1.30B |
| Inventory | $32.03M |
| Noncurrent Assets | $352.60M |
| Fixed Assets | $10.68M |
| Other Non-current Assets | $341.92M |
| Liabilities | $101.38M |
| Current Liabilities | $74.76M |
| Accounts Payable | $19.55M |
| Wages | $19.59M |
| Other Current Liabilities | $35.61M |
| Noncurrent Liabilities | $26.62M |
| Equity | $1.28B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.28B |
| Liabilities And Equity | $1.39B |
| Net Cash Flow From Operating Activities | -$409.93M |
| Net Cash Flow From Operating Activities, Continuing | -$409.93M |
| Net Cash Flow From Investing Activities | $237.95M |
| Net Cash Flow From Investing Activities, Continuing | $237.95M |
| Net Cash Flow From Financing Activities | $10.96M |
| Net Cash Flow From Financing Activities, Continuing | $10.96M |
| Net Cash Flow | -$161.02M |
| Net Cash Flow, Continuing | -$161.02M |
| Comprehensive Income/Loss | -$402.63M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$402.63M |
| Other Comprehensive Income/Loss | -$402.63M |